EPC · Edgewell Personal Care Co - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q2 '26 | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $519.50M | $422.80M | $627.20M | $580.70M | $478.40M | $647.80M | $599.40M | $488.90M | $650.00M | $469.10M |
| Cost of Revenue | $302.60M | $261.80M | $358.70M | $324.50M | $286.80M | $360.70M | $341.30M | $291.20M | $370.30M | $280.10M |
| Gross Profit | $216.90M | $161.00M | $268.50M | $256.20M | $191.60M | $287.10M | $258.10M | $197.70M | $279.70M | $189.00M |
| R&D | $14.90M | $13.80M | $14.00M | $13.90M | $13.90M | $14.60M | $14.20M | $13.30M | $14.80M | $13.40M |
| SG&A | $111.00M | $102.40M | $104.40M | $105.70M | $102.90M | $110.10M | $107.50M | $103.30M | $96.30M | $95.70M |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $11.90M | $21.30M | $13.40M | $13.40M | $21.70M | - | - | $22.50M | - | $22.50M |
| Operating Income | $18.40M | ($18.90M) | $53.70M | $58.90M | $20.30M | $82.70M | $70.10M | $26.10M | $85.60M | $31.30M |
| Interest Expense | $17.90M | $19.30M | $19.40M | $20.20M | $18.80M | $18.80M | $20.40M | $19.80M | $19.20M | $19.90M |
| Income Tax | $3.90M | ($7.70M) | $8.10M | $12.30M | $400.0K | $13.50M | $11.00M | $1.20M | $17.70M | $4.50M |
| Net Income | ($10.60M) | ($65.70M) | $29.10M | $29.00M | ($2.10M) | $49.00M | $36.00M | $4.80M | $52.50M | $11.90M |
| EPS - Basic | ($0.23) | ($1.41) | $0.62 | $0.60 | ($0.04) | $0.99 | $0.72 | $0.10 | $1.03 | $0.23 |
| EPS - Diluted | ($0.22) | ($1.41) | $0.62 | $0.60 | ($0.04) | $0.98 | $0.72 | $0.09 | $1.01 | $0.23 |
Balance Sheet
| Line item | Q2 '26 | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $299.70M | $223.30M | $225.70M | $170.10M | $175.50M | $209.10M | $196.20M | $214.20M | $216.40M | $155.20M |
| Accounts Receivable | $185.40M | $154.00M | $137.80M | $178.20M | $120.50M | $109.40M | $130.60M | $112.50M | $106.20M | $160.80M |
| Inventory | $450.10M | $461.20M | $484.70M | $512.20M | $501.60M | $477.30M | $496.40M | $521.90M | $492.40M | $540.50M |
| Accounts Payable | $231.10M | $213.10M | $219.70M | $215.60M | $203.80M | $219.30M | $219.70M | $197.50M | $194.40M | $245.10M |
| Current Assets | $1.11B | $1.06B | $995.50M | $1.01B | $945.20M | $936.00M | $994.80M | $1.01B | $962.40M | $1.01B |
| Total Assets | $3.53B | $3.77B | $3.76B | $3.77B | $3.70B | $3.73B | $3.76B | $3.79B | $3.74B | $3.80B |
| Current Liabilities | $613.80M | $497.50M | $565.50M | $536.30M | $459.00M | $563.60M | $541.90M | $467.70M | $523.40M | $569.00M |
| Long-term Debt | $1.24B | $1.52B | $1.38B | $1.43B | $1.44B | $1.27B | $1.35B | $1.45B | $1.36B | $1.41B |
| Total Liabilities | $2.09B | $2.28B | $2.20B | $2.26B | $2.20B | $2.15B | $2.21B | $2.24B | $2.20B | $2.29B |
| Stockholders' Equity | $1.45B | $1.49B | $1.55B | $1.51B | $1.50B | $1.58B | $1.55B | $1.55B | $1.54B | $1.51B |
| Retained Earnings | $995.80M | $1.01B | $1.09B | $1.10B | $1.08B | $1.09B | $1.05B | $1.02B | $1.02B | $946.40M |
Cash Flow
| Line item | Q2 '26 | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | ($125.90M) | - | - | ($115.60M) | - | - | ($72.90M) | - | ($86.30M) |
| Investing Cash Flow | - | ($9.90M) | - | - | ($15.70M) | - | - | ($6.00M) | - | ($11.20M) |
| Financing Cash Flow | - | $133.40M | - | - | $109.90M | - | - | $69.80M | - | $82.90M |
| CapEx | - | $11.60M | - | - | $16.80M | - | - | $6.50M | - | $11.30M |
| Free Cash Flow | - | ($137.50M) | - | - | ($132.40M) | - | - | ($79.40M) | - | ($97.60M) |
Ratios
| Metric | Q2 '26 | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 41.8% | 38.1% | 42.8% | 44.1% | 40.1% | 44.3% | 43.1% | 40.4% | 43.0% | 40.3% |
| Operating margin | 3.5% | -4.5% | 8.6% | 10.1% | 4.2% | 12.8% | 11.7% | 5.3% | 13.2% | 6.7% |
| EBITDA margin | 5.8% | 0.6% | 10.7% | 12.5% | 8.8% | - | - | 9.9% | - | 11.5% |
| Net margin | -2.0% | -15.5% | 4.6% | 5.0% | -0.4% | 7.6% | 6.0% | 1.0% | 8.1% | 2.5% |
| Free cash flow margin | - | -32.5% | - | - | -27.7% | - | - | -16.2% | - | -20.8% |
| FCF / Net income | - | 2.09 | - | - | 63.05 | - | - | -16.54 | - | -8.20 |
| R&D / Revenue | 2.9% | 3.3% | 2.2% | 2.4% | 2.9% | 2.3% | 2.4% | 2.7% | 2.3% | 2.9% |
| SG&A / Revenue | 21.4% | 24.2% | 16.6% | 18.2% | 21.5% | 17.0% | 17.9% | 21.1% | 14.8% | 20.4% |
| Effective tax rate | - | - | 21.8% | 29.8% | - | 21.6% | 23.4% | 20.0% | 25.2% | 27.4% |
| Return on assets | -0.3% | -1.7% | 0.8% | 0.8% | -0.1% | 1.3% | 1.0% | 0.1% | 1.4% | 0.3% |
| Return on equity | -0.7% | -4.4% | 1.9% | 1.9% | -0.1% | 3.1% | 2.3% | 0.3% | 3.4% | 0.8% |
| Return on invested capital | 0.5% | -0.5% | 1.4% | 1.4% | 0.5% | 2.3% | 1.9% | 0.7% | 2.2% | 0.8% |
| Liquidity | ||||||||||
| Current ratio | 1.81 | 2.12 | 1.76 | 1.89 | 2.06 | 1.66 | 1.84 | 2.15 | 1.84 | 1.77 |
| Quick ratio | 1.07 | 1.20 | 0.90 | 0.93 | 0.97 | 0.81 | 0.92 | 1.03 | 0.90 | 0.82 |
| Cash ratio | 0.49 | 0.45 | 0.40 | 0.32 | 0.38 | 0.37 | 0.36 | 0.46 | 0.41 | 0.27 |
| Leverage | ||||||||||
| Debt / Equity | 0.86 | 1.02 | 0.89 | 0.95 | 0.96 | 0.80 | 0.87 | 0.94 | 0.88 | 0.94 |
| Debt / Assets | 0.35 | 0.40 | 0.37 | 0.38 | 0.39 | 0.34 | 0.36 | 0.38 | 0.36 | 0.37 |
| Debt / EBITDA | 41.07 | 633.67 | 20.62 | 19.82 | 34.30 | - | - | 29.88 | - | 26.28 |
| Interest coverage | 1.0x | -1.0x | 2.8x | 2.9x | 1.1x | 4.4x | 3.4x | 1.3x | 4.5x | 1.6x |
| Equity multiplier | 2.44 | 2.54 | 2.42 | 2.49 | 2.47 | 2.36 | 2.42 | 2.45 | 2.43 | 2.52 |
| Liabilities / Assets | 0.59 | 0.61 | 0.59 | 0.60 | 0.59 | 0.58 | 0.59 | 0.59 | 0.59 | 0.60 |
| Efficiency | ||||||||||
| Asset turnover | 0.15 | 0.11 | 0.17 | 0.15 | 0.13 | 0.17 | 0.16 | 0.13 | 0.17 | 0.12 |
| Inventory turnover | 0.67 | 0.57 | 0.74 | 0.63 | 0.57 | 0.76 | 0.69 | 0.56 | 0.75 | 0.52 |
| Days sales outstanding | 130d | 133d | 80d | 112d | 92d | 62d | 80d | 84d | 60d | 125d |
| Days inventory outstanding | 543d | 643d | 493d | 576d | 638d | 483d | 531d | 654d | 485d | 704d |
| Days payable outstanding | 279d | 297d | 224d | 243d | 259d | 222d | 235d | 248d | 192d | 319d |
| Cash conversion cycle | 394d | 479d | 350d | 446d | 471d | 323d | 375d | 491d | 353d | 510d |
| Valuation | ||||||||||
| P / E | - | - | 32.8x | 52.0x | - | 37.1x | 53.7x | 407.0x | 36.6x | 184.4x |
| P / B | 0.7x | 0.5x | 0.6x | 1.0x | 1.1x | 1.1x | 1.3x | 1.2x | 1.2x | 1.5x |
| P / S | 1.9x | 1.9x | 1.5x | 2.6x | 3.4x | 2.8x | 3.2x | 3.8x | 2.9x | 4.7x |
| EV / EBITDA | 64.1x | 871.7x | 31.5x | 38.3x | 69.1x | - | - | 63.5x | - | 64.3x |
| Growth | ||||||||||
| Revenue growth (YoY) | -10.5% | -11.6% | -3.2% | -3.1% | -2.1% | -0.3% | - | 4.2% | 4.2% | 1.3% |
| Revenue CAGR (3y) | - | -3.4% | 0.2% | 2.0% | 1.1% | 4.1% | 4.9% | 2.7% | 10.3% | 1.1% |
| Revenue CAGR (5y) | 0.0% | -1.3% | 5.3% | 2.1% | 1.1% | 0.9% | -0.3% | 0.9% | - | - |
| Gross profit growth (YoY) | -15.3% | -16.0% | -6.5% | -0.7% | -3.1% | 2.6% | - | 4.6% | 16.3% | -0.5% |
| Operating income growth (YoY) | -68.8% | - | -35.1% | -16.0% | -22.2% | -3.4% | - | -16.6% | 71.5% | -1.6% |
| Net income growth (YoY) | - | -3028.6% | -40.6% | -19.4% | - | -6.7% | - | -59.7% | 72.1% | 6.3% |
| EPS growth (YoY) | - | -3425.0% | -36.7% | -16.7% | - | -3.0% | - | -60.9% | 77.2% | 15.0% |
| EPS CAGR (3y) | - | - | 2.8% | 11.7% | - | 9.8% | 40.4% | -34.5% | 123.9% | -17.5% |
| EPS CAGR (5y) | - | - | 47.1% | 10.8% | - | - | -4.2% | - | 35.6% | 13.9% |
| FCF growth (YoY) | - | -3.9% | - | - | -66.8% | - | - | 18.6% | - | -10.4% |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -4.3% | -1.0% | -2.0% | -2.4% | -2.9% | 2.8% | - | 2.6% | 5.5% | -2.9% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-09-30.
Business segments
$2.22B totalWet Shave Segment$1.22B · 54.8%
Sunand Skin Care Segment$743.10M · 33.4%
Feminine Care Segment$261.50M · 11.8%
Product / service
$2.22B totalRazorsandblades$1.10B · 49.7%
Suncareproducts$458.90M · 20.6%
Tampons Padsand Liners$261.50M · 11.8%
Infant Careand Other Products$200.60M · 9.0%
Shavinggelsandcreams$114.20M · 5.1%
Skin Care Products$83.60M · 3.8%
Geographic
$2.22B totalUS$1.20B · 54.2%
Non Us$1.02B · 45.8%
Peer comparison
Same SIC group: Perfumes, Cosmetics & Other Toilet Preparations
Comparing EDGEWELL PERSONAL CARE Co against the 5 most active filers in the same SIC group.
Dividends
$0.60/share trailing 12 months · 0.0% YoY
| Ex-date | Per share |
|---|---|
| Mar 6, 2026 | $0.1500 |
| Dec 4, 2025 | $0.1500 |
| Sep 4, 2025 | $0.1500 |
| Jun 6, 2025 | $0.1500 |
| Mar 5, 2025 | $0.1500 |
| Dec 3, 2024 | $0.1500 |
| Sep 4, 2024 | $0.1500 |
| Jun 6, 2024 | $0.1500 |
| Mar 6, 2024 | $0.1500 |
| Dec 5, 2023 | $0.1500 |
| Sep 6, 2023 | $0.1500 |
| Jun 6, 2023 | $0.1500 |
| Mar 7, 2023 | $0.1500 |
| Nov 28, 2022 | $0.1500 |
| Sep 1, 2022 | $0.1500 |
| Jun 1, 2022 | $0.1500 |
| Mar 7, 2022 | $0.1500 |
| Dec 2, 2021 | $0.1500 |
| Sep 8, 2021 | $0.1500 |
| Jun 3, 2021 | $0.1500 |
| Mar 4, 2021 | $0.1500 |
| Dec 9, 2020 | $0.1500 |
| Aug 17, 2015 | $0.2500 |
| May 18, 2015 | $0.3706 |